Which Treatment Should You Choose Today?
Immediate Availability Comparison
Both Mounjaro and Saxenda are currently in full stock at EverydayMeds, ending the uncertainty around treatment availability. Mounjaro (tirzepatide) is available in all six doses from 2.5mg to 15mg, with single pens starting at £129.99 for first-time customers. Saxenda (liraglutide) maintains complete stock coverage across its dosing range. This dual availability means you can make your treatment choice based on clinical suitability rather than stock constraints.
Mounjaro Stock Status
Our Mounjaro inventory includes immediate dispatch capability for all doses. The Intro Duo bundle (2.5mg + 5mg pens) provides your starting doses at £299.99 first order, supporting the standard titration schedule without supply interruption. Higher-strength options including 12.5mg at £259.99 first order and 15mg at £278.99 first order ensure treatment continuity as you progress. Express clinical approval can have your prescription ready within 24 hours.
Treatment Selection Guidance
Mounjaro activates both GIP and GLP-1 receptors, potentially offering enhanced appetite regulation compared to Saxenda's single GLP-1 approach. Both treatments are prescription-only medicines requiring clinical assessment and work alongside reduced-calorie diet and increased physical activity. Mounjaro's once-weekly injection schedule may suit those preferring less frequent dosing, whilst Saxenda's daily injection provides more consistent daily hormone activation.
Pricing Advantage
First-time customers receive £40 OFF all orders with code FIRST40, making Mounjaro's starting dose £129.99 instead of £169.99. Returning customers benefit from £25 OFF every subsequent order, ensuring ongoing affordability. Bundle options provide additional savings - the Progress Trio (5mg, 7.5mg, 10mg) offers three months of titration doses at £634.99 first order, representing significant per-pen savings.
Secure Your Treatment Today
Stock levels remain strong for both treatments, but securing your preferred option eliminates future availability concerns. Our clinical team processes assessments within three working days standard, or 24 hours with express service. Both treatments ship immediately upon prescription approval, with tracked delivery ensuring secure receipt. Complete your clinical questionnaire now to begin treatment selection and avoid potential supply delays.
